The findings, based on an exploratory analysis, indicate that CD47 expression may predict which patients benefit most from the therapy
Envelta is the company’s non-opioid pain product candidate for acute and chronic pain
The use of procalcitonin testing for sepsis management is highest in the US
Domestic devices are usually preferred over imported medical devices in the national or regional procurement.
The govt has rolled out three schemes for promoting the manufacture of API
The successive PLI disbursements validate our disciplined execution and sustained commitment to strengthening India’s domestic pharmaceutical manufacturing capabilities
Lupin’s double ‘A’ rating in Climate and Water exemplifies its steadfast commitment to sustainability
The study evaluated patients with stage III/IV melanoma after complete tumor resection
This drug candidate, which is currently progressing through pivotal clinical studies, has the potential to become the first add-on therapy for schizophrenia patients who do not respond adequately
Subscribe To Our Newsletter & Stay Updated
